Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$120.0 - $182.95 $16,680 - $25,430
139 Added 3.9%
3,702 $466,000
Q4 2023

Jan 10, 2024

BUY
$114.17 - $185.35 $33,223 - $53,936
291 Added 8.89%
3,563 $640,000
Q3 2023

Nov 13, 2023

SELL
$138.78 - $176.51 $39,274 - $49,952
-283 Reduced 7.96%
3,272 $520,000
Q2 2023

Jul 07, 2023

BUY
$138.42 - $180.31 $88,865 - $115,759
642 Added 22.04%
3,555 $502,000
Q1 2023

Apr 19, 2023

BUY
$154.26 - $198.1 $39,336 - $50,515
255 Added 9.59%
2,913 $490,000
Q4 2022

Feb 08, 2023

SELL
$162.42 - $220.56 $17 Million - $23 Million
-104,474 Reduced 97.52%
2,658 $450,000
Q3 2022

Oct 19, 2022

SELL
$160.42 - $256.21 $391,264 - $624,896
-2,439 Reduced 2.23%
107,132 $20.5 Million
Q2 2022

Aug 09, 2022

BUY
$140.68 - $188.02 $6.03 Million - $8.06 Million
42,879 Added 64.29%
109,571 $17.7 Million
Q1 2022

Apr 11, 2022

BUY
$161.19 - $257.96 $1.72 Million - $2.76 Million
10,687 Added 19.08%
66,692 $12.5 Million
Q4 2021

Jan 20, 2022

SELL
$247.59 - $304.47 $210,451 - $258,799
-850 Reduced 1.5%
56,005 $14.8 Million
Q3 2021

Nov 01, 2021

SELL
$194.77 - $324.21 $11.1 Million - $18.4 Million
-56,855 Reduced 50.0%
56,855 $16.6 Million
Q3 2021

Nov 01, 2021

BUY
$194.77 - $324.21 $11.1 Million - $18.5 Million
57,207 Added 101.25%
113,710 $32.9 Million
Q2 2021

Jul 16, 2021

BUY
$165.87 - $220.95 $683,882 - $910,976
4,123 Added 7.87%
56,503 $11.3 Million
Q1 2021

May 17, 2021

BUY
$180.37 - $226.26 $406,734 - $510,216
2,255 Added 4.5%
52,380 $10.1 Million
Q4 2020

Feb 12, 2021

SELL
$148.08 - $206.57 $173,253 - $241,686
-1,170 Reduced 2.28%
50,125 $9.61 Million
Q3 2020

Nov 09, 2020

SELL
$122.51 - $158.27 $6.21 Million - $8.02 Million
-50,661 Reduced 49.69%
51,295 $7.65 Million
Q2 2020

Aug 13, 2020

BUY
$94.33 - $140.48 $4.81 Million - $7.16 Million
50,949 Added 99.89%
101,956 $12.6 Million
Q1 2020

May 15, 2020

BUY
$84.96 - $109.14 $184,533 - $237,052
2,172 Added 4.45%
51,007 $4.92 Million
Q4 2019

Feb 11, 2020

BUY
$73.84 - $93.08 $67,858 - $85,540
919 Added 1.92%
48,835 $4.52 Million
Q3 2019

Nov 13, 2019

BUY
$76.65 - $95.51 $3.67 Million - $4.58 Million
47,916 New
47,916 $3.79 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.87B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Nordea Investment Management Ab Portfolio

Follow Nordea Investment Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.